Mupirocin: study card

Generic name

Mupirocin

Class

Topical RNA synthetase inhibitor antibacterial

Mechanism

Interrupts bacterial protein synthesis by binding reversibly to bacterial isoleucyl-tRNA synthetase.

Used for

Topical treatment of impetigo due to susceptible S. aureus or S. pyogenes in adults and children aged 2 months and older

Common side effects

Burning, stinging or pain; Itching

Warnings

Severe allergic reactions / anaphylaxis; Not for mucosal use; avoid eyes; C. difficile-associated diarrhea

Brand questions use only name pairings verified against the linked product source. Unverified pairings are withheld from these questions; the other study content remains available.

Label date: 20260820 · For learning, not clinical decisions. US label and brand information; always consult the current source.

Source snapshot checked: 2026-10-21. The source document and selected fields were compared. The complete card has not had an independent clinical review.